Could stroke trials be missing important treatment effects?

被引：28

作者：

Berge, E

Barer, D ^{[1
]}

机构：

[1] Queen Elizabeth Hosp, Stroke Res Team, Gateshead NE9 6SX, England

[2] Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland

来源：

CEREBROVASCULAR DISEASES | 2002年 / 13卷 / 01期

关键词：

D O I：

10.1159/000047752

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：73 / 75

页数：3

共 8 条

[1] Clinical trials - Simple megatrials are not sufficient [J].

Barer, D .

BRITISH MEDICAL JOURNAL, 1999, 318 (7191) :1138-1138

[2]

BARER D, 1998, CEREBROVASC DIS, V8, P47

[3] Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials [J].

Collins, R ;

MacMahon, S .

LANCET, 2001, 357 (9253) :373-380

[4] THE CLINICAL MEANING OF RANKIN HANDICAP GRADES AFTER STROKE [J].

DEHAAN, R ;

LIMBURG, M ;

BOSSUYT, P ;

VANDERMEULEN, J ;

AARONSON, N .

STROKE, 1995, 26 (11) :2027-2030

[5]

HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017

[6] Bootstrap statistics of ECASS II data: Just another post hoc analysis of a negative stroke trial? [J].

Stingele, R ;

Bluhmki, E ;

Hacke, W .

CEREBROVASCULAR DISEASES, 2001, 11 (01) :30-33

[7]

VANGIJN J, 1992, CEREBROVASC DIS, V2, P244

[8] INTEROBSERVER AGREEMENT FOR THE ASSESSMENT OF HANDICAP IN STROKE PATIENTS [J].

VANSWIETEN, JC ;

KOUDSTAAL, PJ ;

VISSER, MC ;

SCHOUTEN, HJA ;

VANGIJN, J .

STROKE, 1988, 19 (05) :604-607

← 1 →